Teprotumumab appears effective for patients with chronic thyroid eye disease

Investigators assessed the use of teprotumumab for patients with chronic thyroid eye disease (TED) with a low clinical activity score (CAS).
Source: AAO

Posted in: Uncategorized

Leave a response

Quick Links

Expertise

Our Locations

Malta, NY
658 Malta Ave, Suite 101
Malta, NY 12020

Tel: 518-580-0553
Get Directions »

Troy, NY
2200 Burdett Avenue, Suite 206
Troy, New York 12180

Tel: 518-580-0553
Get Directions »

Clifton Park(EyesNY), NY
1712 Route 9,
Halfmoon, NY 12065

Tel: +1 (518) 580-0553
Get Directions »

map
map
map
658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553